Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.65 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | GAA | P10253 | 2/20 | 0.60 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.59 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.57 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.57 |
| ▸ | HTR1A | P08908 | 1/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6228768 | 0.87 | HDAC3 (0.68) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL3244156 | 0.86 | HPGD (0.68) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL5672650 | 0.86 | DPP8 (0.61) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL19931588 | 0.84 | HDAC3 (0.65) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL9138101 | 0.83 | HDAC3 (0.71) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL6580790 | 0.83 | HDAC3 (0.71) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL5385138 | 0.83 | HDAC3 (0.67) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL13059439 | 0.83 | HDAC3 (0.67) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL13487712 | 0.83 | HDAC3 (0.67) | HDAC3HDAC1HDAC10HDAC11HPGD | |
| SCHEMBL5380082 | 0.83 | HDAC3 (0.67) | HDAC3HDAC1HDAC10HDAC11HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3507275-B1 | CXCR3 RECEPTOR AGONISTS | RECEPTOS LLC (US) | 2023-04-26 | — | — | EP | disclosed |
| WO-2018045246-A1 | CXCR3 RECEPTOR AGONISTS | CELGENE INTERNATIONAL II SARL (CH) | 2018-03-08 | — | — | WO | disclosed |
| US-8367700-B2 | Substituted 4-(1.2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators | GRUENENTHAL GMBH (DE) | 2013-02-05 | — | — | US | disclosed |
| EP-2358681-A1 | SUBSTITUTED 4-(1,2,3,4-TETRAHYDROISOCHINOLIN-2-YL)-4-OXO-BUTYRIC ACID AMIDE AS KCNQ2/2 MODULATORS | Grünenthal GmbH (DE) | 2011-08-24 | — | — | EP | disclosed |
| WO-2010075973-A1 | SUBSTITUTED 4-(1,2,3,4-TETRAHYDROISOCHINOLIN-2-YL)-4-OXO-BUTYRIC ACID AMIDE AS KCNQ2/2 MODULATORS | Grünenthal GmbH (DE) | 2010-07-08 | — | — | WO | disclosed |
| US-20100152234-A1 | Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators | GRUNENTHAL GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| WO-2008008502-A1 | 4-AMINO-4-OXOBUTANOYL PEPTIDES AS INHIBITORS OF VIRAL REPLICATION | ACHILLION PHARMACEUTICALS, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152234-A1 | Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators | KCNAB1, KCNQ2, KCNQ1 | HDAC3 297/4885HDAC1 1884/4885HDAC10 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.